Express Pharma

Glenmark appoints Philip Andrew Gioia as President North America and Global API business

0 127

Glenmark Pharmaceuticals has appointed Philip Andrew Gioia as President North America and Global API business. Gioia has taken charge of his responsibilities and will be based at Mahwah, NJ, US. He will be reporting into the Glenn Saldanha, Chairman and Managing Director, Glenmark.

In this role, Gioia will be responsible for the Generics and Branded business across North America as also the Global API Sales and Marketing. Gioia has over 25 years of experience in the US pharmaceutical industry both in the generics and the branded space.

On his appointment, Glenn Saldanha, Chairman and Managing Director, Glenmark said, “We believe that with Gioia’s rich and diversified experience across the generics and branded pharmaceutical businesses as well as business development, brings the necessary skills and acumen to lead and grow the North American operations and the API business of Glenmark.”

Gioia joins Glenmark from Bausch & Lomb (acquired by Valeant Pharmaceuticals, August 2013), where his career spanned nearly five years most recently as Global Head of Diversified Products and Business Development, Pharmaceuticals. He worked significantly on expanding Bausch & Lomb’s product pipeline. Prior to that, he was Division Head – Pharmaceutical Business Unit, North America. His responsibilities included all aspects of P&L management in addition to overall strategic commercial operations for the brand, generic and OTC divisions.

Preceding Bausch & Lomb, Gioia enjoyed 13 years of increased responsibility at Barr Pharmaceuticals from 1995 until January 2009 (acquired by Teva Pharmaceuticals). He joined the generic business assuming increasing levels of responsibility, then built Barr’s branded business as VP/SVP of Sales which included a 300+ person sales force focused on Women’s Health. In 2007, Gioia was appointed Senior Vice President(SVP) of the $1.6 billion US Generic Sales & Marketing business where he was involved in the portfolio planning, manufacturing, logistics and supply chain activities. He led the forecasting group, and was very involved in product selection, planning, and logistics; ensuring the best in class customer service with respect to supply and quality within the trade.

EP News Bureau Mumbai

- Advertisement -

Leave A Reply

Your email address will not be published.